Business · 10/06/2015Updated: 10/17/2026 · 1 min read
FDA Announces Approval of Comparative Price Information Collection
Summary
The Food and Drug Administration (FDA) has announced that it has received approval from the Office of Management and Budget (OMB) to collect comparative price information in direct-to-consumer and professional prescription drug advertisements, as required by the Paperwork Reduction Act of 1995.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →